Three BALB/c monoclonal antibodies capable of neutralizing herpes simplex virus type 1 (HSV-1) were used to prepare rabbit anti-idiotypic antisera. Affinity-purified antibodies from four of these rabbits were used to immunize mice by repeated subcutaneous injection over a period of 6 to 7 weeks: the mice were then challenged with HSV-1 subcutaneously in the ear pinna. Measurement of ear swelling showed that prior administration of anti-idiotypic serum could generate dose-dependent delayedtype hypersensitivity responses.
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Time (days) Fig. 1 . Mean daily ear swelling increments over normal in groups of six mice immunized with absorbed anti-LP 2 eluate I. Unit doses were given five times at weekly intervals. Unit doses were : A, 18 ~tg antiidiotype; B1,6 ~tg anti-idiotype; B2,2 ~tg anti-idiotype; C, 0.6 ~tg anti-idiotype; Col, 2 ~tg rabbit gamma globulin; Co2, control group (no treatment). Test virus dose given 1 week later was 10 p.f.u. HSV-1 intradermally in left ear pinna with 'recall' injections of 10 p.f.u, into right ear on day 18. Swelling increments over normal were recorded on days 1 and 2 after injection. ascitic fluid of a different specificity. After absorption, the sera were negative at 1/10 with heterospecific coated SRBC and gave specific agglutination, with a satisfactory preparation of SRBC, to a titre of 1:50000 or better. For affinity purification of antibody, specific immunosorbents were made by attaching purified monoclonal antibody Ig to CNBr-activated Sepharose at 1 mg per g. After washing of the gel, antibody Ig or crude antiserum was added; after 10 min shaking the deposit was thoroughly washed with saline, and the absorbed antibody eluted with 0.1 M-glycine-HC1 pH 2.8. The eluate was rapidly neutralized with solid disodium tetraborate and dialysed against saline. Eluted antibody was usually found to be at a protein concentration of 0.1 to 1.0 mg/ml. BALB/c mice were immunized in groups of six. Five deep intradermal injections were given at weekly intervals. Mice were tested by intradermal injections of virus into the ear pinnae, and the subsequent ear swelling was measured over the next 5 days with a Mitutoyo engineer's micrometer.
The 'recall' injections were made similarly in the other ear; doses etc. are given in the legends of Fig. 1 and 2 . Statistical comparisons were made between groups by means of Wilcoxon ranking tests; that is, the probability that both groups come from the same population is estimated (see Colquhoun, 1971) . Fig. 1 illustrates the results with an eluate from serum R II raised against LP 2. Five groups of six mice were sensitized as described above, using five weekly doses of 0.6, 2.0, 6.0 or 18.0 ~tg of the affinity-purified eluate of anti-LP 2. The control groups received either 2-0 ~tg of normal rabbit Ig or no treatment. One week after the end of this injection Course, all the mice were tested by injection into the left ear pinna of 10 p.f.u.HSV-1 (Sc 16) in 0.01 ml (day 0) and ear thickness was measured daily up to day 4, three mice in each group having the ear removed after day 3 for virus titration. The results plotted are the measurements after subtraction of the mean thickness of the normal, untreated ears; they are the means of six mice in each group (apart from day 4). There was a marked peak in two of the test groups (B and C) at the second day whereas the control groups (Col and Co,_) started low and continued to rise; the group that received normal rabbit Ig was indistinguishable from that which received no treatment. Using a Wilcoxon ranking test, the probability that each of the test groups at this day came from the same population as the combined control groups was < 0.01 in each case; the differences between these and test group A which received the largest dose were not significant. On days 4 and 5 there were significant (<0.01) depressions of the combined test groups (B~ + B2) below the level of the combined control groups (Co~ + Co2).
The results of the 'recall' test of all groups on days 28 + 1 and 28 + 2 illustrate in the control groups what sort of values are to be expected from pre-sensitized mice, and in the 'test' groups the absence of any signs at this stage of suppression or induced tolerance resulting from the pretreatment with anti-idiotype; that is to say, the results in all groups were as expected for normal mice after sensitization by the test dose of virus. Fig. 2 shows the results with eluates corresponding to LP 14, LP l 1 and an eluate (2) from serum of another rabbit (R XI) immunized with LP 2. Doses for sensitization were (A) 0.4, (B) 2.0 or (C) 10 ~tg and (Co) 2.0 ~tg of rabbit Ig for the control groups. In this case the values shown are those obtained after subtraction of the mean value of a control unimmunized group at day 1. Fig. 2(d) shows the results after immunization with all three eluates simultaneously; the dose of each idiotype was as before, but the total dose reckoned as rabbit Ig was three times as much. Note that the same control group (Co, six mice) is used in all four graphs. Compared with Fig. 1 , the peaks in each were I day later, and as before showed significances of <0.01 by the Wilcoxon test, apart from the results in Fig. 2 (d) , which were only marginally significant (< 0.05). The aim of this last group was to ascertain whether reactivity to three different determinants would produce markedly more intense responses than that to one alone, but this was clearly not the case.
We conclude that statistically significant differences between immunized and control groups were found at the second or third day after testing, at a time when the maximum response is to be expected in pre-sensitized mice. This was evident in all five experiments recorded using four different anti-idiotypic eluates. This indicates that delayed hypersensitivity has been induced by the anti-idiotype. A positive response of this nature is in contrast to the results of Kennedy et al. (1984) using a HSV system, who found suppressor responses; this is not altogether surprising since they used different antisera in different doses. In our system, the immunizing dose of anti-idiotype has been found to be critical; a change of unit dose from 2 ~tg to 20 ~tg largely abolishes any positive effect. In most experiments there was a sharp fall in swelling between day 3 and day 5; although this is often observable after re-testing a normally sensitized mouse, it is possible that some suppressive effect supervenes at this time. Our data are unfortunately not adequate to demonstrate this, if it occurs. In other systems including hapten systems, a positive delayed response has frequently been demonstrated (for references, see Kennedy & Dreesman, 1985) .
One experiment was done (not shown) in which 1 to 6 p.g doses of the eluates were injected into the ears of mice pre-sensitized with HSV; no positive results were recorded. This is not surprising in view of the polyclonal nature of the anti-HSV response; whether or not our antiidiotypes have actually modelled epitopes of the virus, there is no reason to expect that the particular epitopes we have used involve a major part of the normal total response of the mouse to HSV.
Although it has been observed (Nash & Gell, 1981) that there is some correlation between delayed hypersensitivity and protection as judged by accelerated clearance of virus from the ear, we were not able to demonstrate this using ears taken at the fourth day from some of the mice used in the above experiments, including that illustrated in Fig. 2(d) . However, work along these lines is being pursued. We are also studying the possible 'switch-on' of antibodies bearing the immunizing idiotypes in the serum of the immunized mice.
